1 7178835943 | [email protected]

ICND · Registering as Listener

International Conference on Neonatal Diabetes

17th Mar – 18th Mar 2027 Bursa, Turkey Standard / Physical Participation

Listener Registration From

$—

$— in person

Registration Benefits:

Official invitation letterIssued automatically after registration

Certificate & digital materialsGet certificate, slides and resource materials

Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

Standard / Physical $—

On-site keynotes, talks, workshops, networking, conference kit and certificate.

Select

Virtual $—

Live streaming access to all sessions, digital materials and certificate.

Select

All sessions Networking Certificate Invitation letter Conference kit

Amount:

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

Full Name *

Email Address *

Mobile Number *

City *

State *

Country *

Zip / Postal Code

Address

Credit Card

Debit Card

Net Banking

Cash Card

Unified Payments

For Support Please Contact

[email protected]

Coupon code

Have a code? Apply it here — the discount updates the total immediately.

Apply

I agree to the Terms & Conditions and Refund & Cancellation Policy

VISA MC AMEX UPI

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceICND

ModeStandard / Physical

ParticipationListener

Registration fee$—

Bank charges (5.8%)$—

Discount-$0.00

Total payable $—

Includes all bank processing charges — the amount above is exactly what will be charged. View charge breakdown

Need help?

Contact our registration team:

1 7178835943

[email protected]

Benefits of Registering as Listener

Access to Conference Sessions

Networking Opportunities

Certificate of Participation

Invitation Letter Support

Conference Kit / Materials

Access to Keynote Sessions

Conference Session Tracks

SDG-Aligned Research Themes

International Conference on Neonatal Diabetes conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 9 - Industry, Innovation and Infrastructure

This track focuses on the latest findings in neonatal diabetes, including genetic and environmental factors influencing its onset. Researchers will present innovative approaches to diagnosis and management in this vulnerable population.

This session will explore the autoimmune processes underlying Type 1 diabetes and related disorders. Discussions will include the role of immune interventions and potential therapeutic strategies.

This track will address the challenges and management strategies associated with gestational diabetes. Experts will discuss its long-term implications for both mothers and children.

Focusing on rare forms of diabetes, this session will delve into monogenic diabetes and idiopathic cases. Presentations will highlight diagnostic challenges and personalized treatment options.

This track will examine the unique aspects of diabetes management in children and adolescents. Topics will include early diagnosis, treatment strategies, and psychosocial considerations.

This session will cover the various complications associated with diabetes, including cardiovascular, renal, and neurological issues. Researchers will present findings on prevention and management strategies.

This track will showcase cutting-edge technologies for diabetes management, including continuous glucose monitoring and insulin delivery systems. Discussions will focus on their impact on patient outcomes.

This session will highlight the role of computational methods in understanding diabetes pathophysiology and treatment. Presentations will include data analytics, modeling, and simulation studies.

This track will feature case discussions that emphasize patient-oriented approaches in endocrinology. Experts will share insights on individualized care plans for diabetes patients.

This session will focus on the discovery of new biomarkers and therapeutic agents for diabetes treatment. Researchers will discuss the implications of these advancements for clinical practice.

This track will address the regulatory challenges and economic considerations in diabetes research and treatment. Discussions will include funding, policy implications, and market access.